Published in Circulation on June 01, 1986
The effects of early coronary patency on the evolution of myocardial infarction: a prospective arteriographic study. Br Heart J (1987) 1.09
Prognostic significance of ST-T segment alterations in patients with non-Q wave myocardial infarction. Heart (1996) 1.05
Cardiovascular magnetic resonance of scar and ischemia burden early after acute ST elevation and non-ST elevation myocardial infarction. J Cardiovasc Magn Reson (2008) 0.84
Role of age and sex in short-term and long term mortality after a first Q wave myocardial infarction. J Epidemiol Community Health (2001) 0.83
Report of the Canadian Cardiovascular Society's consensus conference on the Management of the Postmyocardial Infarction Patient. CMAJ (1991) 0.80
Management of acute non-Q-wave myocardial infarction. The role of prophylactic diltiazem therapy and indications for predischarge coronary arteriography. Drugs (1991) 0.77
Acute non-Q-wave myocardial infarction: a distinct clinical entity of increasing importance. CMAJ (1988) 0.77
Potential of combined thromboxane A2 and serotonin antagonists to prevent the development of unstable angina and acute myocardial infarction. Tex Heart Inst J (1990) 0.76
Residual myocardial jeopardy in patients with Q-wave and non-Q-wave infarctions. Br Heart J (1987) 0.75
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med (1993) 7.19
Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med (1971) 3.27
Psychological factors related to prehospital delay during acute myocardial infarction. Circulation (1991) 2.88
Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. N Engl J Med (1986) 2.26
Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol (1992) 2.18
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J (1997) 2.16
Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med (1989) 2.15
Hospital-based pneumococcal immunization. Epidemiologic rationale from the Shenandoah study. JAMA (1990) 2.14
A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol (1991) 2.08
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA (1996) 1.99
Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control (1989) 1.98
Chronic traumatic thoracic aneurysm. Influence of operative treatment on natural history: an analysis of reported cases, 1950-1980. J Thorac Cardiovasc Surg (1982) 1.95
Multiple use of disposable insulin syringe-needle units. JAMA (1980) 1.89
Relation between surgical volume and incidence of postoperative wound infection. N Engl J Med (1981) 1.87
Clinical effectiveness of influenza vaccination in Manitoba. JAMA (1993) 1.78
Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy. Am J Med (1995) 1.73
Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation (1977) 1.73
Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS) Circulation (1993) 1.66
Postinfarction ventricular septal rupture: the importance of location of infarction and right ventricular function in determining survival. Circulation (1986) 1.63
Relationship between extent of residual myocardial viability and coronary flow reserve in patients with recent myocardial infarction. Am Heart J (2001) 1.62
Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab (1987) 1.58
Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med (1986) 1.56
Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation (1997) 1.55
Health perceptions of primary care patients and the influence on health care utilization. Med Care (1989) 1.53
Improvement in hypertension in patients with diabetes mellitus after kidney/pancreas transplantation. Circulation (2001) 1.50
Improving preventive care at a medical clinic: how can the patient help? Am J Prev Med (1990) 1.50
Lower thrombolytic use for African Americans with myocardial infarction: an influence of clinical presentation? Am Heart J (1999) 1.49
Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol (1989) 1.48
Estimating severity of chronic heart failure: a clinical challenge for the 1990s. Am Heart J (1992) 1.47
Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation (1983) 1.46
Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme. J Am Coll Cardiol (1998) 1.46
Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population. J Am Coll Cardiol (2001) 1.46
Atrial extension of mitral annular calcification mimicking intracardiac tumor. Clin Cardiol (1987) 1.45
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation (1994) 1.43
Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol (1988) 1.43
Optimal heart rate control for patients with chronic atrial fibrillation: are pharmacologic choices truly changing? Am Heart J (1992) 1.40
Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides. Eur J Heart Fail (2008) 1.40
Optimal timing for initial and redistribution technetium 99m-N-NOET image acquisition. J Nucl Cardiol (2000) 1.39
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol (2001) 1.38
Effect of N-0861, a selective adenosine A1 receptor antagonist, on pharmacologic stress imaging with adenosine. J Nucl Med (1995) 1.38
Improvement in left ventricular systolic function after pericardiocentesis: case report. Henry Ford Hosp Med J (1989) 1.38
Relation between plasma norepinephrine and response to medical therapy in men with congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol (1989) 1.38
Assessment of residual coronary stenoses using 99mTc-N-NOET vasodilator stress imaging to evaluate coronary flow reserve early after coronary reperfusion in a canine model of subendocardial infarction. J Nucl Med (2001) 1.38
Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. Thorax (1989) 1.36
Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation (1999) 1.36
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J (1999) 1.36
The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol (1997) 1.34
Contemporary aspects of discrete peak-detection algorithms. I. The paradigm of the luteinizing hormone pulse signal in men. Endocr Rev (1988) 1.33
Tissue heating during radiofrequency catheter ablation: a thermodynamic model and observations in isolated perfused and superfused canine right ventricular free wall. Pacing Clin Electrophysiol (1989) 1.33
Joint efforts across national boundaries between professional organizations in cardiovascular medicine: one way into the future. Eur Heart J (2000) 1.31
Demographics and cardiology, 1950-2050. J Am Coll Cardiol (2000) 1.30
Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm. Am J Cardiol (1983) 1.29
Localization of cardiac myosin-specific antibody in myocardial infarction. J Clin Invest (1976) 1.27
Electrocardiographic evolution of posterior acute myocardial infarction: importance of early precordial ST-segment depression. Am J Cardiol (1987) 1.25
Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol (1996) 1.25
Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds. Antimicrob Agents Chemother (1988) 1.25
Urinary tract etiology of bloodstream infections in hospitalized patients. J Infect Dis (1983) 1.24
Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man. Lancet (1983) 1.23
Complications of femoral artery closure devices. Catheter Cardiovasc Interv (2001) 1.22
Precordial ST-segment depression during acute inferior myocardial infarction: clinical, scintigraphic and angiographic correlations. Circulation (1982) 1.21
The zinc nutriture of preschool children living in two African countries. J Nutr (1993) 1.17
Determining prognosis after acute myocardial infarction in the thrombolytic era. BMJ (1997) 1.13
Adverse reactions to antiarrhythmic drugs during therapy for ventricular arrhythmias. JAMA (1986) 1.13
Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. Am Heart J (1997) 1.12
Ischemia-induced alterations in myocardial (Na+ + K+)-ATPase and cardiac glycoside binding. J Clin Invest (1976) 1.12
Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms. Pediatr Infect Dis J (1988) 1.11
T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations. Kidney Int (1987) 1.11
Iron deficiency and risk factors for lower iron stores in 6-24-month-old New Zealanders. Eur J Clin Nutr (2004) 1.10
The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988. Am Heart J (1990) 1.09
A randomized trial of ecadotril versus placebo in patients with mild to moderate heart failure: the U.S. ecadotril pilot safety study. Am Heart J (1999) 1.09
Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. J Am Coll Cardiol (1983) 1.08
Pulmonary edema after pericardiocentesis for cardiac tamponade. N Engl J Med (1983) 1.07
A comprehensive analysis of myocardial infarction due to left circumflex artery occlusion: comparison with infarction due to right coronary artery and left anterior descending artery occlusion. J Am Coll Cardiol (1988) 1.06